CAS: 19983-28-9

VPC-14228 is a non-steroidal compound that targets the bromodomain, a protein found in cancer cells. Bromodomain inhibition has been shown to disrupt cancer progression by regulating cellular proliferation and death. VPC-14228 has shown anti-cancer properties in vitro and in vivo models. It can also be taken orally, which makes it an attractive candidate for the treatment of cancers.

VPC-14228

4-(4-Phenyl-1,3-Thiazol-2-Yl)Morpholine

VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.